It seems HIV and TB are falling by the wayside in the drive to stop the spread of COVID-19. Where we can we must minimise the harm to the HIV and TB response, and we need to see the opportunity to address all three diseases together, writes Erica Penfold.
Tuberculosis (TB) testing rates are down by almost half and dramatically fewer TB patients are starting treatment. Kathryn Cleary takes an in-depth look at the impact of COVID-19 and the lockdown on TB services in South Africa.
The use of the BCG vaccine for an unproven indication is irresponsible and may deplete BCG stocks for young children, for whom it has been proven to be a lifesaving preventive tool against TB, argue a group of leading experts.
Medicines that taste like strawberries or mangos, cutting edge trials on preventing TB in kids, measuring how children’s bodies take up TB medicines – in this World TB Day feature Kathryn Cleary profiles the amazing research done by the Desmond Tutu TB Centre in Cape Town.
In 2018 the United States invested $371 million in tuberculosis research and development (R&D). South Africa invested $4.5 million (R64,9 million) – a dramatic decrease on 2017, but still high when measured as a proportion of all R&D spending in the country.